These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35155241)

  • 1. Differential Impact of Membrane-Bound and Soluble Forms of the Prognostic Marker Syndecan-1 on the Invasiveness, Migration, Apoptosis, and Proliferation of Cervical Cancer Cells.
    Hilgers K; Ibrahim SA; Kiesel L; Greve B; Espinoza-Sánchez NA; Götte M
    Front Oncol; 2022; 12():803899. PubMed ID: 35155241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
    Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
    Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells.
    Javadi J; Heidari-Hamedani G; Schmalzl A; Szatmári T; Metintas M; Aspenström P; Hjerpe A; Dobra K
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Heparan Sulfate Proteoglycan Syndecan-1 Triggers Breast Cancer Cell-Induced Coagulability by Induced Expression of Tissue Factor.
    Hassan N; Bückreiß N; Efing J; Schulz-Fincke M; König P; Greve B; Bendas G; Götte M
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical/prognostic significance of Syndecan-1 expression in invasive breast carcinoma with distant metastasis and its correlation with tumor immunity.
    Wang H; Zhang Y; Yang Z; Jiang Y; Wu L; Wang R; Zhang Z
    Pathol Res Pract; 2023 Oct; 250():154787. PubMed ID: 37678063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
    Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
    FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.
    Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H
    J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndecan-1 serves as a marker for the progression of epithelial ovarian carcinoma.
    Guo Q; Yang X; Ma Y; Ma L
    Eur J Gynaecol Oncol; 2015; 36(5):506-13. PubMed ID: 26513873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.
    Hu Y; Sun H; Owens RT; Gu Z; Wu J; Chen YQ; O'Flaherty JT; Edwards IJ
    Neoplasia; 2010 Oct; 12(10):826-36. PubMed ID: 20927321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer.
    Wang X; Zuo D; Chen Y; Li W; Liu R; He Y; Ren L; Zhou L; Deng T; Wang X; Ying G; Ba Y
    Br J Cancer; 2014 Nov; 111(10):1965-76. PubMed ID: 25321193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
    Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
    Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.
    Stepp MA; Pal-Ghosh S; Tadvalkar G; Rajjoub L; Jurjus RA; Gerdes M; Ryscavage A; Cataisson C; Shukla A; Yuspa SH
    Mol Carcinog; 2010 Apr; 49(4):363-73. PubMed ID: 20082322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.
    Lu Z; Song N; Shen B; Xu X; Fang Y; Shi Y; Ning Y; Hu J; Dai Y; Ding X; Zou J; Teng J
    Transplantation; 2018 Jul; 102(7):e331-e344. PubMed ID: 29557914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment.
    Prieto-Fernández E; Egia-Mendikute L; Bosch A; García Del Río A; Jimenez-Lasheras B; Antoñana-Vildosola A; Lee SY; Palazon A
    Front Immunol; 2020; 11():586977. PubMed ID: 33117401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry.
    Yu KJ; Bashirova A; Madeleine MM; Cheng J; Johnson LG; Schwartz SM; Carrington M; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2504-8. PubMed ID: 18006945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
    Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
    Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype.
    De Oliveira T; Abiatari I; Raulefs S; Sauliunaite D; Erkan M; Kong B; Friess H; Michalski CW; Kleeff J
    Mol Cancer; 2012 Apr; 11():19. PubMed ID: 22471946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer.
    Sanaee MN; Malekzadeh M; Khezri A; Ghaderi A; Doroudchi M
    Urol Int; 2015; 94(4):472-8. PubMed ID: 25115297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
    Charni F; Friand V; Haddad O; Hlawaty H; Martin L; Vassy R; Oudar O; Gattegno L; Charnaux N; Sutton A
    Biochim Biophys Acta; 2009 Oct; 1790(10):1314-26. PubMed ID: 19632304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.